Sodium Benzoate vs Blue Dye 1: which is worse?

What is Sodium Benzoate?

Sodium benzoate is the sodium salt of benzoic acid (C7H5NaO2). In acidic foods and beverages, it converts to benzoic acid, which inhibits microbial growth. While benzoic acid occurs naturally in some fruits and spices at low levels, the commercial preservative is synthetically manufactured.

What is Blue Dye 1?

Blue Dye 1 (Brilliant Blue FCF) is a synthetic blue triarylmethane dye derived from petroleum. It produces a brilliant sky-blue color and is highly water-soluble. Unlike the azo dyes (Red 40, Yellow 5/6), Blue 1 belongs to the triarylmethane chemical class.

Documented risks

Sodium Benzoate: Sodium benzoate's most significant documented concern is the benzene formation reaction. When sodium benzoate coexists with ascorbic acid (vitamin C) in acidic conditions, they react in the presence of metal ions (iron, copper) and UV light to produce benzene, an IARC Group 1 human carcinogen. FDA surveys in 2005-2007 found benzene exceeding the EPA drinking water standard (5 ppb) in 79 of 200 commercial beverages tested. This triggered voluntary reformulations across the beverage industry. The 2007 McCann et al. Lancet study showed that the combination of sodium benzoate with six artificial food dyes significantly increased hyperactivity in children — the effect was synergistic, with the combination producing greater behavioral effects than either ingredient alone. This finding led directly to the EU's mandatory warning label requirement for products combining sodium benzoate with specified dyes. A 2010 study in ADHD: Attention Deficit and Hyperactivity Disorders found associations between urinary sodium benzoate/hippuric acid metabolite levels and ADHD symptom severity in children, independent of dye exposure. A 2019 study in Nutrients (PMC6520673) found similar associations in Korean children. Mitochondrial DNA damage: Dr. Peter Piper at the University of Sheffield found that sodium benzoate at concentrations used in some beverages could damage mitochondrial DNA in yeast cells, potentially affecting mitochondrial function. These findings have not been fully replicated in human tissue studies. Hypersensitivity reactions including urticaria, angioedema, and contact dermatitis are documented. Cross-reactivity with aspirin has been reported in aspirin-sensitive individuals.

Blue Dye 1: Blue Dye 1 was historically banned in several European countries before EU harmonization permitted it (as E133). EFSA's 2010 comprehensive safety re-evaluation found no evidence of carcinogenicity in standard animal tests. The ADI was set at 6 mg/kg body weight. The most significant documented safety concern for Blue 1 involves intravenous/enteral administration rather than dietary intake. In 2003, the FDA issued a Public Health Advisory warning against using Blue 1 (used as a food coloring agent in enteral nutrition formulas to detect aspiration in critically ill patients) after multiple case reports — including deaths — documented that Blue 1 can be absorbed through damaged intestinal mucosa and cause cardiovascular instability, metabolic acidosis, and death. The FDA advisory specifically warned against this clinical use in intensive care patients. This is a medical use concern, not a dietary intake concern. For healthy consumers eating normally, EFSA found no significant safety concerns at food use levels. Blue 1 was not included in the 2007 Lancet hyperactivity study. However, it falls under the FDA's April 2025 announcement to phase out all petroleum-based synthetic food dyes, reflecting updated policy on the class as a whole rather than specific Blue 1 data. Historically, Blue 1 was banned in multiple European countries due to safety concerns, though EU harmonization later permitted it with E-number labeling requirements. This history suggests precautionary concern even when formal regulatory action was not sustained.